Resting heart rate and cardiovascular events: risk factor or risk marker?

Ker, James
August 2012
South African Pharmaceutical Journal;2012, Vol. 79 Issue 4, p45
Academic Journal
The article discusses the association of resting heart rate with all-cause mortality in addition to cardiovascular mortality. According to the Framingham Heart study, high resting heart rate is associated with an increase in cardiovascular mortality in people and also found in people with hypertension, acute myocardial infarction and heart failure and ventricular dysfunction. It also presents information on the heart rate-lowering drug, ivabradine.


Related Articles

  • Heart rate: surrogate or target in the management of heart failure? Böhm, Michael; Reil, Jan-Christian // Heart;Jan2013, Vol. 99 Issue 2, p72 

    The author reflects on the role of heart rate in the management of heart failures. It focuses on high resting heart rates, which may result in cardiovascular diseases like atherosclerosis, myocardial infarction and heart failure. High heart rates are a reflection of neurohormonal activation and...

  • Effect of Chronic Heart Rate Reduction by If Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure. Dedkov, Eduard I.; Bogatyryov, Yevgen; McCooey, Daniela Scaldaferri; Christensen, Lance P.; Weiss, Robert M.; Tomanek, Robert J. // Journal of Cardiovascular Pharmacology & Therapeutics;May2015, Vol. 20 Issue 3, p299 

    The article focuses on a study which determines whether long-term inhibitor ivabradine (IVA) therapy can sustainably maintain the beneficial impact of pure heart rate reduction on left ventricular (LV) remodeling and systolic performance in middle-aged rats with heart failure (HF) due to a large...

  • Lack of B vitamins may clog arteries.  // Environmental Nutrition;Mar1995, Vol. 18 Issue 3, p1 

    Reports on the findings of the Framingham Heart Study on high blood levels of the amino acid homocysteine as an important indicator of risk for heart attack. Increase in risk in lower blood levels of B vitamin folate and vitamin B6.

  • Blood pressure warning...  // FDA Consumer;Jan/Feb2000, Vol. 34 Issue 1, p5 

    Reveals the findings of a Framingham Heart Study showing the dangers of not treating people with elevated systolic high blood pressure. Move of the United States (US) National Institutes of Health about the findings; How systolic blood pressure is produced; People in the US with high blood...

  • Genetic linkage analysis of longitudinal hypertension phenotypes using three summary measures. Shaoqi Rao; Lin Li; Xia Li; Moser, Kathy L.; Zheng Guo; Gongqing Shen; Cannata, Ruth; Zirzow, Erich; Topol, Eric J.; Qing Wang // BMC Genetics;2003 Supplement 1, Vol. 4, pS24 

    Background: Longitudinal data often have multiple (repeated) measures recorded along a time trajectory. For example, the two cohorts from the Framingham Heart Study (GAW13 Problem 1) contain 21 and 5 repeated measures for hypertension phenotypes as well as epidemiological risk factors,...

  • Lack of reproducibility of linkage results in serially measured blood pressure data. Patel, Sanjay R.; Celedon, Juan C.; Weiss, Scott T.; Palmer, Lyle J. // BMC Genetics;2003 Supplement 1, Vol. 4, pS37 

    Background: Using the longitudinal Framingham Heart Study data on blood pressure, we analyzed the reproducibility of linkage measures from serial cross-sectional surveys of a defined population by performing genome-wide model-free linkage analyses to systolic blood pressure (SBP) and history of...

  • The Value Of Antihypertensive Drugs: A Perspective On Medical Innovation. Cutler, David M.; Long, Genia; Berndt, Ernst R.; Royer, Jimmy; Fournier, Andrée-Anne; Sasser, Alicia; Cremleux, Pierre // Health Affairs;Jan/Feb2007, Vol. 26 Issue 1, p97 

    Using national survey data and risk equations from the Framingham Heart Study, we quantify the impact of antihypertensive therapy changes on blood pressures and the number and cost of heart attacks, strokes, and deaths. Antihypertensive therapy has had a major impact on health. Without it,...

  • Homocysteine: The Rubik's Cube of Cardiovascular Risk Factors.  // Mayo Clinic Proceedings;Nov2008, Vol. 83 Issue 11, p1200 

    The article discusses the risk factors for the development of heart disease, based on the cohort study of director Thomas R. Dawber at Framingham Heart Study. The Framingham risk management tool is used to calculate the risk of developing a myocardial infarction and at the same time used as...

  • Pulse Pressure and Risk of New-Onset Atrial Fibrillation. Mitchell, Gary F.; Vasan, Ramachandran S.; Keyes, Michelle J.; Parise, Helen; Wang, Thomas J.; Larson, Martin G.; D'Agostino, Ralph B.; Kannel, William B.; Levy, Daniel; Benjamin, Emelia J. // JAMA: Journal of the American Medical Association;2/21/2007, Vol. 297 Issue 7, p709 

    The article presents research examining the relations between pulse pressure and the incidence of atrial fibrillation (AF), which poses a high rate of morbidity and mortality. The database of the Framingham (Massachusetts) Heart Study was mined for over 5000 adult patients initially free of AF....


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics